CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 18 enrolled
Drug / intervention
oral Vancomycin +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02504554
NCT02504554Phase 2Completed
CompareCT.gov

Treating Gastrointestinal Problems in Children With Autism Using Beneficial Bacteria Treatment (BBT)

Arizona State University·interventional·Posted Jul 22, 2015·Updated Sep 12, 2025

In Brief

A Phase 2 clinical trial evaluating oral Vancomycin, MoviPrep, and 3 other interventions for Gastrointestinal Problems and Autism Spectrum Disorders. Completed, enrolled 18 participants.

Detailed Summary

This is an open-label clinical trial to investigate a combination therapy for treating gastrointestinal problems in children with autism spectrum disorders. The combination therapy includes beneficial bacteria.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Problems, Autism Spectrum Disorders
Countries--
CollaboratorsNorthern Arizona University, University of Arizona, University of Minnesota

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 22, 2015
Enrollment StartJul 1, 2014
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 10.9 years ago

Interventions

oral Vancomycindrug

an antibiotic

MoviPrepdrug

a bowel cleanse

Prilosecdrug

a stomach acid suppressan

human fecal material; processed, frozen administered orallybiological

human fecal material; processed, frozen, administered orally

human fecal material; processed, frozen; administered orally and rectallybiological

human fecal material; processed, frozen; administered orally and rectally